In the News

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

Written by Cleerly | June 20, 2022

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning. Cleerly has developed a cardiology care management system based on image analysis and AI, to help clinicians personalize a patient's heart attack risk so they can determine who needs intensive management—and who doesn't.

Download the article now, to read the full interview.

 

 

About Cleerly

Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine intelligence, Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway. For more information, please visit: https://www.cleerlyhealth.com.

Cleerly Press Contact:

press@cleerlyhealth.com